Resistance mechanisms in Campylobacter jejuni

References

• Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg 2008; 102:123 - 9; http://dx.doi.org/10.1016/j.trstmh.2007.09.019; PMID: 18023831
   PubMed Web of Science ®Google Scholar
• Eurosurveillance editorial team. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. Euro Surveill 2012; 17:20113; PMID: 22433599
   PubMedGoogle Scholar
• EFSA. The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008. Eur Food Safety Auth J 2010; 8:1658 - 919
   Google Scholar
• OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell 2010; 34:396 - 426; PMID: 21413526
   PubMedGoogle Scholar
• Notifiable and Other Diseases in New Zealand. Annula Report 2011. In: The Institute of Environmental Science and Research Ltd. Porirua, New Zealand; 2012.
   Google Scholar
• Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell, ed. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010:2793-802.
   Google Scholar
• Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev 1983; 5:157 - 76; PMID: 6357819
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Incidence of foodborne illnesses: preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet)--United States, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:189 - 94; PMID: 10208124
   PubMedGoogle Scholar
• FoodNet - Foodborne Diseases Active Surveillance Network. Centers for Disease Control and Prevention, 2012. (Accessed March 14, 2012, at http://www.cdc.gov/foodnet/.)
   Google Scholar
• Thomas C, Gibson H, Hill DJ, Mabey M. Campylobacter epidemiology: an aquatic perspective. J Appl Microbiol 1998; 85:Suppl 1 168S - 77S; http://dx.doi.org/10.1111/j.1365-2672.1998.tb05296.x; PMID: 21182706
   PubMedGoogle Scholar
• Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27:199 - 208; http://dx.doi.org/10.1093/jac/27.2.199; PMID: 2055811
   PubMed Web of Science ®Google Scholar
• Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, et al, NARMS Working Group. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis 2004; 10:1102 - 9; http://dx.doi.org/10.3201/eid1006.030635; PMID: 15207064
   PubMed Web of Science ®Google Scholar
• Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 2009; 4:189 - 200; http://dx.doi.org/10.2217/17460913.4.2.189; PMID: 19257846
   PubMed Web of Science ®Google Scholar
• Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al, Investigation Team. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340:1525 - 32; http://dx.doi.org/10.1056/NEJM199905203402001; PMID: 10332013
   PubMed Web of Science ®Google Scholar
• Threlfall EJ, Ward LR, Frost JA, Willshaw GA. Spread of resistance from food animals to man--the UK experience. Acta Vet Scand Suppl 2000; 93:63 - 8, discussion 68-74; PMID: 10822859
   PubMedGoogle Scholar
• van Boven M, Veldman KT, de Jong MC, Mevius DJ. Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J Antimicrob Chemother 2003; 52:719 - 23; http://dx.doi.org/10.1093/jac/dkg402; PMID: 12951353
   PubMed Web of Science ®Google Scholar
• Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7:337 - 41; http://dx.doi.org/10.3201/eid0702.010239; PMID: 11294736
   PubMed Web of Science ®Google Scholar
• Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JS, Fanning S, et al. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 2006; 8:1955 - 66; http://dx.doi.org/10.1016/j.micinf.2005.12.030; PMID: 16716632
   PubMed Web of Science ®Google Scholar
• Kittl S, Kuhnert P, Hächler H, Korczak BM. Comparison of genotypes and antibiotic resistance of Campylobacter jejuni isolated from humans and slaughtered chickens in Switzerland. J Appl Microbiol 2011; 110:513 - 20; http://dx.doi.org/10.1111/j.1365-2672.2010.04906.x; PMID: 21143711
   PubMed Web of Science ®Google Scholar
• Monitoring antimicrobial usage in food animals for the protection of human health: Report of a WHO consultation. World Health Organization Department of Communicable Disease, Surveillance and Response 2001.
   Google Scholar
• Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al, Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331 - 51; http://dx.doi.org/10.1086/318514; PMID: 11170940
   PubMed Web of Science ®Google Scholar
• Sarmah AK, Meyer MT, Boxall AB. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 2006; 65:725 - 59; http://dx.doi.org/10.1016/j.chemosphere.2006.03.026; PMID: 16677683
   PubMed Web of Science ®Google Scholar
• Council regulation (EC) No. 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorization of certain antibiotics, Directive 70/524/EEC concerning additives in feedingstuffs. Official Journal of the European Communities 1998; 351:4 - 8
   Google Scholar
• Ansary A, Radu S. Conjugal transfer of antibiotic resistances and plasmids from Campylobacter jejuni clinical isolates. FEMS Microbiol Lett 1992; 70:125 - 8; http://dx.doi.org/10.1111/j.1574-6968.1992.tb05196.x; PMID: 1587459
   PubMedGoogle Scholar
• Bradbury WC, Munroe DL. Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals. J Clin Microbiol 1985; 22:339 - 46; PMID: 4044793
   PubMed Web of Science ®Google Scholar
• Gibreel A, Sköld O. High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases. Antimicrob Agents Chemother 1998; 42:3059 - 64; PMID: 9835491
   PubMed Web of Science ®Google Scholar
• Gibreel A, Sköld O, Taylor DE. Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni. Microb Drug Resist 2004; 10:98 - 105; http://dx.doi.org/10.1089/1076629041310127; PMID: 15256024
   PubMed Web of Science ®Google Scholar
• Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR, Taylor DE. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob Agents Chemother 2004; 48:3442 - 50; http://dx.doi.org/10.1128/AAC.48.9.3442-3450.2004; PMID: 15328109
   PubMed Web of Science ®Google Scholar
• Lambert T, Gerbaud G, Trieu-Cuot P, Courvalin P. Structural relationship between the genes encoding 3′-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol 1985; 136B:135 - 50; http://dx.doi.org/10.1016/S0769-2609(85)80040-5; PMID: 3002237
   PubMedGoogle Scholar
• Lee MD, Sanchez S, Zimmer M, Idris U, Berrang ME, McDermott PF. Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Antimicrob Agents Chemother 2002; 46:3660 - 4; http://dx.doi.org/10.1128/AAC.46.11.3660-3664.2002; PMID: 12384387
   PubMed Web of Science ®Google Scholar
• Nirdnoy W, Mason CJ, Guerry P. Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob Agents Chemother 2005; 49:2454 - 9; http://dx.doi.org/10.1128/AAC.49.6.2454-2459.2005; PMID: 15917546
   PubMed Web of Science ®Google Scholar
• O’Halloran F, Lucey B, Cryan B, Buckley T, Fanning S. Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp. J Antimicrob Chemother 2004; 53:952 - 7; http://dx.doi.org/10.1093/jac/dkh193; PMID: 15128721
   PubMed Web of Science ®Google Scholar
• Pinto-Alphandary H, Mabilat C, Courvalin P. Emergence of aminoglycoside resistance genes aadA and aadE in the genus Campylobacter. Antimicrob Agents Chemother 1990; 34:1294 - 6; http://dx.doi.org/10.1128/AAC.34.6.1294; PMID: 2168151
   PubMed Web of Science ®Google Scholar
• Sagara H, Mochizuki A, Okamura N, Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother 1987; 31:713 - 9; http://dx.doi.org/10.1128/AAC.31.5.713; PMID: 3038005
   PubMed Web of Science ®Google Scholar
• Velázquez JB, Jiménez A, Chomón B, Villa TG. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 1995; 35:173 - 8; http://dx.doi.org/10.1093/jac/35.1.173; PMID: 7768766
   PubMed Web of Science ®Google Scholar
• Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 2002; 46:2124 - 31; http://dx.doi.org/10.1128/AAC.46.7.2124-2131.2002; PMID: 12069964
   PubMed Web of Science ®Google Scholar
• Pumbwe L, Piddock LJ. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett 2002; 206:185 - 9; http://dx.doi.org/10.1111/j.1574-6968.2002.tb11007.x; PMID: 11814661
   PubMed Web of Science ®Google Scholar
• Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003; 71:4250 - 9; http://dx.doi.org/10.1128/IAI.71.8.4250-4259.2003; PMID: 12874300
   PubMed Web of Science ®Google Scholar
• Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 2006; 57:52 - 60; http://dx.doi.org/10.1093/jac/dki419; PMID: 16303882
   PubMed Web of Science ®Google Scholar
• Jeon B, Wang Y, Hao H, Barton YW, Zhang Q. Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J Antimicrob Chemother 2011; 66:79 - 85; http://dx.doi.org/10.1093/jac/dkq418; PMID: 21081547
   PubMed Web of Science ®Google Scholar
• Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403:665 - 8; http://dx.doi.org/10.1038/35001088; PMID: 10688204
   PubMed Web of Science ®Google Scholar
• Corcoran D, Quinn T, Cotter L, Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents 2006; 27:40 - 5; http://dx.doi.org/10.1016/j.ijantimicag.2005.08.019; PMID: 16318913
   PubMed Web of Science ®Google Scholar
• Kurincic M, Botteldoorn N, Herman L, Smole Mozina S. Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans. Int J Food Microbiol 2007; 120:186 - 90; http://dx.doi.org/10.1016/j.ijfoodmicro.2007.03.012; PMID: 17889390
   PubMed Web of Science ®Google Scholar
• Pumbwe L, Randall LP, Woodward MJ, Piddock LJ. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother 2004; 54:341 - 7; http://dx.doi.org/10.1093/jac/dkh331; PMID: 15201231
   PubMed Web of Science ®Google Scholar
• Page WJ, Huyer G, Huyer M, Worobec EA. Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother 1989; 33:297 - 303; http://dx.doi.org/10.1128/AAC.33.3.297; PMID: 2543277
   PubMed Web of Science ®Google Scholar
• Jeon B, Muraoka W, Scupham A, Zhang Q. Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother 2009; 63:462 - 8; http://dx.doi.org/10.1093/jac/dkn529; PMID: 19147521
   PubMed Web of Science ®Google Scholar
• Karmali MA, De Grandis S, Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother 1981; 19:593 - 7; http://dx.doi.org/10.1128/AAC.19.4.593; PMID: 7247381
   PubMed Web of Science ®Google Scholar
• Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence 2011; 2:30 - 40; http://dx.doi.org/10.4161/viru.2.1.14752; PMID: 21266840
   PubMed Web of Science ®Google Scholar
• Taylor DE, Ng LK, Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother 1985; 28:708 - 10; http://dx.doi.org/10.1128/AAC.28.5.708; PMID: 3004325
   PubMed Web of Science ®Google Scholar
• van Mourik A, Steeghs L, van Laar J, Meiring HD, Hamstra HJ, van Putten JP, et al. Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem 2010; 285:15828 - 36; http://dx.doi.org/10.1074/jbc.M110.102061; PMID: 20351099
   PubMed Web of Science ®Google Scholar
• Akhtar SQ. Antimicrobial sensitivity and plasmid-mediated tetracycline resistance in Campylobacter jejuni isolated in Bangladesh. Chemotherapy 1988; 34:326 - 31; http://dx.doi.org/10.1159/000238587; PMID: 3208549
   PubMed Web of Science ®Google Scholar
• Boonmar S, Sangsuk L, Suthivarakom K, Padungtod P, Morita Y. Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand. Southeast Asian J Trop Med Public Health 2005; 36:130 - 4; PMID: 15906655
   PubMedGoogle Scholar
• Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998; 26:341 - 5; http://dx.doi.org/10.1086/516303; PMID: 9502453
   PubMed Web of Science ®Google Scholar
• National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). Human Isolates Final Report, 2010. U.S. Department of Health and Human Services, CDC, 2012. (Accessed at http://www.cdc.gov/narms/reports.htm.)
   Google Scholar
• DANMAP. 2011. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. In: The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; 2012.
   Google Scholar
• Van Looveren M, Daube G, De Zutter L, Dumont JM, Lammens C, Wijdooghe M, et al. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother 2001; 48:235 - 40; http://dx.doi.org/10.1093/jac/48.2.235; PMID: 11481294
   PubMed Web of Science ®Google Scholar
• Davidson D. In the matter of enrofloxacin for poultry: Withdrawal of approval of Bayer Corporation's new animal drug application 1 (NADA) 140-828 (Baytril). In: FDA Docket No 00N-1571 2004; 2004.
   Google Scholar
• Miflin JK, Templeton JM, Blackall PJ. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from poultry in the South-East Queensland region. J Antimicrob Chemother 2007; 59:775 - 8; http://dx.doi.org/10.1093/jac/dkm024; PMID: 17392353
   PubMed Web of Science ®Google Scholar
• Unicomb LE, Ferguson J, Stafford RJ, Ashbolt R, Kirk MD, Becker NG, et al, Australian Campylobacter Subtyping Study Group. Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis 2006; 42:1368 - 74; http://dx.doi.org/10.1086/503426; PMID: 16619147
   PubMed Web of Science ®Google Scholar
• Norström M, Hofshagen M, Stavnes T, Schau J, Lassen J, Kruse H. Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect 2006; 134:127 - 30; http://dx.doi.org/10.1017/S0950268805004814; PMID: 16409659
   PubMed Web of Science ®Google Scholar
• Jain D, Sinha S, Prasad KN, Pandey CM. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg 2005; 99:207 - 14; http://dx.doi.org/10.1016/j.trstmh.2004.09.006; PMID: 15653123
   PubMed Web of Science ®Google Scholar
• Bester LA, Essack SY. Observational study of the prevalence and antibiotic resistance of Campylobacter spp. from different poultry production systems in KwaZulu-Natal, South Africa. J Food Prot 2012; 75:154 - 9; http://dx.doi.org/10.4315/0362-028X.JFP-11-237; PMID: 22221370
   PubMed Web of Science ®Google Scholar
• Chokboonmongkol C, Patchanee P, Gölz G, Zessin KH, Alter T. Prevalence, quantitative load, and antimicrobial resistance of Campylobacter spp. from broiler ceca and broiler skin samples in Thailand. Poult Sci 2013; 92:462 - 7; http://dx.doi.org/10.3382/ps.2012-02599; PMID: 23300314
   PubMed Web of Science ®Google Scholar
• Haruna M, Sasaki Y, Murakami M, Ikeda A, Kusukawa M, Tsujiyama Y, et al. Prevalence and antimicrobial susceptibility of Campylobacter in broiler flocks in Japan. Zoonoses Public Health 2012; 59:241 - 5; http://dx.doi.org/10.1111/j.1863-2378.2011.01441.x; PMID: 22103704
   PubMed Web of Science ®Google Scholar
• Wardak S, Szych J, Zasada AA, Gierczynski R. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Antimicrob Agents Chemother 2007; 51:1123 - 5; http://dx.doi.org/10.1128/AAC.01187-06; PMID: 17210776
   PubMed Web of Science ®Google Scholar
• Sáenz Y, Zarazaga M, Lantero M, Gastanares MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 2000; 44:267 - 71; http://dx.doi.org/10.1128/AAC.44.2.267-271.2000; PMID: 10639348
   PubMed Web of Science ®Google Scholar
• Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jørgensen F, Piddock LJ. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents Chemother 2005; 49:699 - 707; http://dx.doi.org/10.1128/AAC.49.2.699-707.2005; PMID: 15673754
   PubMed Web of Science ®Google Scholar
• Price LB, Johnson E, Vailes R, Silbergeld E. Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environ Health Perspect 2005; 113:557 - 60; http://dx.doi.org/10.1289/ehp.7647; PMID: 15866763
   PubMed Web of Science ®Google Scholar
• Price LB, Lackey LG, Vailes R, Silbergeld E. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect 2007; 115:1035 - 9; http://dx.doi.org/10.1289/ehp.10050; PMID: 17637919
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lin J, Pereira S. Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Anim Health Res Rev 2003; 4:63 - 71; http://dx.doi.org/10.1079/AHR200356; PMID: 15134291
   PubMedGoogle Scholar
• Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, et al. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A 2005; 102:541 - 6; http://dx.doi.org/10.1073/pnas.0408966102; PMID: 15634738
   PubMed Web of Science ®Google Scholar
• Ge B, McDermott PF, White DG, Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2005; 49:3347 - 54; http://dx.doi.org/10.1128/AAC.49.8.3347-3354.2005; PMID: 16048946
   PubMed Web of Science ®Google Scholar
• Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 2003; 47:390 - 4; http://dx.doi.org/10.1128/AAC.47.1.390-394.2003; PMID: 12499221
   PubMed Web of Science ®Google Scholar
• Yan M, Sahin O, Lin J, Zhang Q. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J Antimicrob Chemother 2006; 58:1154 - 9; http://dx.doi.org/10.1093/jac/dkl412; PMID: 17023497
   PubMed Web of Science ®Google Scholar
• Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61:377 - 92; PMID: 9293187
   PubMed Web of Science ®Google Scholar
• Shea ME, Hiasa H. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes. J Biol Chem 1999; 274:22747 - 54; http://dx.doi.org/10.1074/jbc.274.32.22747; PMID: 10428858
   PubMed Web of Science ®Google Scholar
• Willmott CJ, Critchlow SE, Eperon IC, Maxwell A. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J Mol Biol 1994; 242:351 - 63; http://dx.doi.org/10.1006/jmbi.1994.1586; PMID: 7932695
   PubMed Web of Science ®Google Scholar
• Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist 2001; 7:257 - 61; http://dx.doi.org/10.1089/10766290152652800; PMID: 11759087
   PubMed Web of Science ®Google Scholar
• Cooper R, Segal H, Lastovica AJ, Elisha BG. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. J Appl Microbiol 2002; 93:241 - 9; http://dx.doi.org/10.1046/j.1365-2672.2002.01650.x; PMID: 12147072
   PubMed Web of Science ®Google Scholar
• Payot S, Cloeckaert A, Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist 2002; 8:335 - 43; http://dx.doi.org/10.1089/10766290260469606; PMID: 12523631
   PubMed Web of Science ®Google Scholar
• Gootz TD, Martin BA. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother 1991; 35:840 - 5; http://dx.doi.org/10.1128/AAC.35.5.840; PMID: 1649570
   PubMed Web of Science ®Google Scholar
• Jesse TW, Englen MD, Pittenger-Alley LG, Fedorka-Cray PJ. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle. J Appl Microbiol 2006; 100:682 - 8; http://dx.doi.org/10.1111/j.1365-2672.2005.02796.x; PMID: 16553723
   PubMed Web of Science ®Google Scholar
• Farnell MB, Donoghue AM, Cole K, Reyes-Herrera I, Blore PJ, Donoghue DJ. Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone concentrations within the gastrointestinal tracts of chickens. J Appl Microbiol 2005; 99:1043 - 50; http://dx.doi.org/10.1111/j.1365-2672.2005.02712.x; PMID: 16238734
   PubMed Web of Science ®Google Scholar
• McDermott PF, Bodeis SM, English LL, White DG, Walker RD, Zhao S, et al. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. J Infect Dis 2002; 185:837 - 40; http://dx.doi.org/10.1086/339195; PMID: 11920303
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ishihara K, Kojima A, Asai T, Harada K, Tamura Y. Emergence of fluoroquinolone resistance in Campylobacter jejuni in chickens exposed to enrofloxacin treatment at the inherent dosage licensed in Japan. J Vet Med B Infect Dis Vet Public Health 2005; 52:460 - 4; http://dx.doi.org/10.1111/j.1439-0450.2005.00890.x; PMID: 16364022
   PubMedGoogle Scholar
• Ellis-Pegler RB, Hyman LK, Ingram RJ, McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother 1995; 36:259 - 63; http://dx.doi.org/10.1093/jac/36.1.259; PMID: 8537277
   PubMed Web of Science ®Google Scholar
• Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992; 165:667 - 70; http://dx.doi.org/10.1093/infdis/165.4.667; PMID: 1313069
   PubMed Web of Science ®Google Scholar
• Wretlind B, Strömberg A, Ostlund L, Sjögren E, Kaijser B. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scand J Infect Dis 1992; 24:685 - 6; http://dx.doi.org/10.3109/00365549209054659; PMID: 1465591
   PubMed Web of Science ®Google Scholar
• Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jimenez De Anta T, et al. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol 1998; 42:223 - 6; PMID: 9580533
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang WM, Taylor DE. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother 1993; 37:457 - 63; http://dx.doi.org/10.1128/AAC.37.3.457; PMID: 8384814
   PubMed Web of Science ®Google Scholar
• Piddock LJ, Ricci V, Pumbwe L, Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother 2003; 51:19 - 26; http://dx.doi.org/10.1093/jac/dkg033; PMID: 12493783
   PubMed Web of Science ®Google Scholar
• Engberg J, Neimann J, Nielsen EM, Aerestrup FM, Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 2004; 10:1056 - 63; http://dx.doi.org/10.3201/eid1006.030669; PMID: 15207057
   PubMed Web of Science ®Google Scholar
• Feodoroff FB, Lauhio AR, Sarna SJ, Hänninen ML, Rautelin HI. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. Clin Microbiol Infect 2009; 15:188 - 92; http://dx.doi.org/10.1111/j.1469-0691.2008.02657.x; PMID: 19154485
   PubMed Web of Science ®Google Scholar
• Helms M, Simonsen J, Olsen KE, Mølbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis 2005; 191:1050 - 5; http://dx.doi.org/10.1086/428453; PMID: 15747238
   PubMed Web of Science ®Google Scholar
• Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. J Infect Dis 2004; 190:1150 - 7; http://dx.doi.org/10.1086/423282; PMID: 15319866
   PubMed Web of Science ®Google Scholar
• Sonnevend A, Kovács J, Pál T, Akawi N, Nagelkerke N, Schneider G. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance. Scand J Infect Dis 2011; 43:905 - 11; http://dx.doi.org/10.3109/00365548.2011.603743; PMID: 21905953
   PubMed Web of Science ®Google Scholar
• Wassenaar TM, Kist M, de Jong A. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents 2007; 30:195 - 201; http://dx.doi.org/10.1016/j.ijantimicag.2007.01.019; PMID: 17420115
   PubMed Web of Science ®Google Scholar
• Asai T, Harada K, Ishihara K, Kojima A, Sameshima T, Tamura Y, et al. Association of antimicrobial resistance in Campylobacter isolated from food-producing animals with antimicrobial use on farms. Jpn J Infect Dis 2007; 60:290 - 4; PMID: 17881869
   PubMed Web of Science ®Google Scholar
• Animal Drugs @ FDA. Center for Veterinary Medicine, 2012. (Accessed at http://www.accessdata.fda.gov/scripts/animaldrugsatfda/index.cfm.)
   Google Scholar
• Cagliero C, Mouline C, Cloeckaert A, Payot S. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2006; 50:3893 - 6; http://dx.doi.org/10.1128/AAC.00616-06; PMID: 16940070
   PubMed Web of Science ®Google Scholar
• Lin J, Yan M, Sahin O, Pereira S, Chang YJ, Zhang Q. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother 2007; 51:1678 - 86; http://dx.doi.org/10.1128/AAC.01411-06; PMID: 17353243
   PubMed Web of Science ®Google Scholar
• Payot S, Bolla JM, Corcoran D, Fanning S, Mégraud F, Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect 2006; 8:1967 - 71; http://dx.doi.org/10.1016/j.micinf.2005.12.032; PMID: 16713726
   PubMed Web of Science ®Google Scholar
• Egger R, Korczak BM, Niederer L, Overesch G, Kuhnert P. Genotypes and antibiotic resistance of Campylobacter coli in fattening pigs. Vet Microbiol 2012; 155:272 - 8; http://dx.doi.org/10.1016/j.vetmic.2011.08.012; PMID: 21899961
   PubMed Web of Science ®Google Scholar
• Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006; 58:243 - 55; http://dx.doi.org/10.1093/jac/dkl210; PMID: 16735431
   PubMed Web of Science ®Google Scholar
• Lachance N, Gaudreau C, Lamothe F, Larivière LA. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother 1991; 35:813 - 8; http://dx.doi.org/10.1128/AAC.35.5.813; PMID: 1854162
   PubMed Web of Science ®Google Scholar
• Lehtopolku M, Kotilainen P, Haanperä-Heikkinen M, Nakari UM, Hänninen ML, Huovinen P, et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2011; 55:5939 - 41; http://dx.doi.org/10.1128/AAC.00314-11; PMID: 21911571
   PubMed Web of Science ®Google Scholar
• Mamelli L, Prouzet-Mauléon V, Pagès JM, Mégraud F, Bolla JM. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005; 56:491 - 7; http://dx.doi.org/10.1093/jac/dki253; PMID: 16055509
   PubMed Web of Science ®Google Scholar
• Pérez-Boto D, López-Portolés JA, Simón C, Valdezate S, Echeita MA. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains. J Antimicrob Chemother 2010; 65:2083 - 8; http://dx.doi.org/10.1093/jac/dkq268; PMID: 20647243
   PubMed Web of Science ®Google Scholar
• Ren GW, Wang Y, Shen Z, Chen X, Shen J, Wu C. Rapid detection of point mutations in domain V of the 23S rRNA gene in erythromycin-resistant Campylobacter isolates by pyrosequencing. Foodborne Pathog Dis 2011; 8:375 - 9; http://dx.doi.org/10.1089/fpd.2010.0676; PMID: 21166562
   PubMed Web of Science ®Google Scholar
• Vacher S, Menard A, Bernard E, Santos A, Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb Drug Resist 2005; 11:40 - 7; http://dx.doi.org/10.1089/mdr.2005.11.40; PMID: 15770093
   PubMed Web of Science ®Google Scholar
• Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, Ravel J, et al. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol 2005; 3:e15; http://dx.doi.org/10.1371/journal.pbio.0030015; PMID: 15660156
   PubMed Web of Science ®Google Scholar
• Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother 2007; 51:3212 - 6; http://dx.doi.org/10.1128/AAC.01592-06; PMID: 17606685
   PubMed Web of Science ®Google Scholar
• Payot S, Avrain L, Magras C, Praud K, Cloeckaert A, Chaslus-Dancla E. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents 2004; 23:468 - 72; http://dx.doi.org/10.1016/j.ijantimicag.2003.12.008; PMID: 15120725
   PubMed Web of Science ®Google Scholar
• Logue CM, Danzeisen GT, Sherwood JS, Thorsness JL, Mercier BM, Axtman JE. Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility. J Appl Microbiol 2010; 109:1379 - 88; http://dx.doi.org/10.1111/j.1365-2672.2010.04765.x; PMID: 20497488
   PubMed Web of Science ®Google Scholar
• Almofti YA, Dai M, Sun Y, Haihong H, Yuan Z. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Microb Pathog 2011; 50:336 - 42; http://dx.doi.org/10.1016/j.micpath.2011.02.009; PMID: 21377522
   PubMed Web of Science ®Google Scholar
• Han F, Pu S, Wang F, Meng J, Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents 2009; 34:462 - 6; http://dx.doi.org/10.1016/j.ijantimicag.2009.06.019; PMID: 19651494
   PubMed Web of Science ®Google Scholar
• Hao H, Dai M, Wang Y, Peng D, Liu Z, Yuan Z. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb Drug Resist 2009; 15:239 - 44; http://dx.doi.org/10.1089/mdr.2009.0008; PMID: 19857128
   PubMed Web of Science ®Google Scholar
• Zeitouni S, Collin O, Andraud M, Ermel G, Kempf I. Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni. Microb Drug Resist 2012; 18:101 - 8; http://dx.doi.org/10.1089/mdr.2011.0188; PMID: 22324770
   PubMed Web of Science ®Google Scholar
• EFSA. The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. Eur Food Safety Auth J 2012; 10:2598 - 830
   Google Scholar
• Smith SI, Sansa TI, Coker AO. Antibiotic susceptibility patterns and beta-lactamase production of animal and human isolates of Campylobacter in Lagos, Nigeria. Z Naturforsch C 1999; 54:583 - 6; PMID: 10488568
   PubMed Web of Science ®Google Scholar
• Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S, et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 2005; 49:2753 - 9; http://dx.doi.org/10.1128/AAC.49.7.2753-2759.2005; PMID: 15980346
   PubMed Web of Science ®Google Scholar
• Caldwell DB, Wang Y, Lin J. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob Agents Chemother 2008; 52:3947 - 54; http://dx.doi.org/10.1128/AAC.00450-08; PMID: 18779354
   PubMed Web of Science ®Google Scholar
• Jeon B, Zhang Q. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. J Antimicrob Chemother 2009; 63:946 - 8; http://dx.doi.org/10.1093/jac/dkp067; PMID: 19279049
   PubMed Web of Science ®Google Scholar
• Huyer MP, Hancock T, Page RW. Outer membrane porin protein of Campylobacter jejuni.. FEMS Microbiol Lett 1986; 37:247 - 50; http://dx.doi.org/10.1111/j.1574-6968.1986.tb01803.x
   Web of Science ®Google Scholar
• Hancock RE, Bell A. Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1988; 7:713 - 20; http://dx.doi.org/10.1007/BF01975036; PMID: 2850910
   PubMed Web of Science ®Google Scholar
• Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrob Agents Chemother 1993; 37:354 - 6; http://dx.doi.org/10.1128/AAC.37.2.354; PMID: 8383945
   PubMed Web of Science ®Google Scholar
• Logan SM, Trust TJ. Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun 1984; 45:210 - 6; PMID: 6203838
   PubMed Web of Science ®Google Scholar
• Naess V, Hofstad T. Isolation and chemical composition of lipopolysaccharide from Campylobacter jejuni. Acta Pathol Microbiol Immunol Scand B 1982; 90:135 - 9; PMID: 7080831
   PubMedGoogle Scholar
• Giesbrecht P, Kersten T, Maidhof H, Wecke J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev 1998; 62:1371 - 414; PMID: 9841676
   PubMed Web of Science ®Google Scholar
• Alfredson DA, Korolik V. Isolation and expression of a novel molecular class D beta-lactamase, OXA-61, from Campylobacter jejuni. Antimicrob Agents Chemother 2005; 49:2515 - 8; http://dx.doi.org/10.1128/AAC.49.6.2515-2518.2005; PMID: 15917560
   PubMed Web of Science ®Google Scholar
• Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A, Piddock LJ. Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother 2009; 53:3357 - 64; http://dx.doi.org/10.1128/AAC.01655-08; PMID: 19506058
   PubMed Web of Science ®Google Scholar
• Lachance N, Gaudreau C, Lamothe F, Turgeon F. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Antimicrob Agents Chemother 1993; 37:1174 - 6; http://dx.doi.org/10.1128/AAC.37.5.1174; PMID: 8390812
   PubMed Web of Science ®Google Scholar
• Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother 1996; 40:1924 - 5; PMID: 8843305
   PubMed Web of Science ®Google Scholar
• Wright EP, Knowles MA. Beta-lactamase production by Campylobacter jejuni. J Clin Pathol 1980; 33:904 - 5; http://dx.doi.org/10.1136/jcp.33.9.904-b; PMID: 6968758
   PubMed Web of Science ®Google Scholar
• Alfredson DA, Korolik V. Identification of putative zinc hydrolase genes of the metallo-beta-lactamase superfamily from Campylobacter jejuni. FEMS Immunol Med Microbiol 2007; 49:159 - 64; http://dx.doi.org/10.1111/j.1574-695X.2006.00197.x; PMID: 17266723
   PubMed Web of Science ®Google Scholar
• Potter ME, Blaser MJ, Sikes RK, Kaufmann AF, Wells JG. Human Campylobacter infection associated with certified raw milk. Am J Epidemiol 1983; 117:475 - 83; PMID: 6837559
   PubMed Web of Science ®Google Scholar
• Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. [second page, table of contents.] Microbiol Mol Biol Rev 2001; 65:232 - 60; http://dx.doi.org/10.1128/MMBR.65.2.232-260.2001; PMID: 11381101
   PubMed Web of Science ®Google Scholar
• Bolla JM, Loret E, Zalewski M, Pagés JM. Conformational analysis of the Campylobacter jejuni porin. J Bacteriol 1995; 177:4266 - 71; PMID: 7543469
   PubMed Web of Science ®Google Scholar
• Kervella M, Fauchère JL, Fourel D, Pagès JM. Immunological cross-reactivity between outer membrane pore proteins of Campylobacter jejuni and Escherichia coli. FEMS Microbiol Lett 1992; 78:281 - 5; http://dx.doi.org/10.1111/j.1574-6968.1992.tb05582.x; PMID: 1337053
   PubMedGoogle Scholar
• Epe B, Woolley P, Hornig H. Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli. FEBS Lett 1987; 213:443 - 7; http://dx.doi.org/10.1016/0014-5793(87)81539-9; PMID: 3104093
   PubMed Web of Science ®Google Scholar
• Goldman RA, Hasan T, Hall CC, Strycharz WA, Cooperman BS. Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis. Biochemistry 1983; 22:359 - 68; http://dx.doi.org/10.1021/bi00271a020; PMID: 6337627
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Hiratsuka K, Taylor DE. Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene 1988; 62:17 - 26; http://dx.doi.org/10.1016/0378-1119(88)90576-8; PMID: 2836268
   PubMed Web of Science ®Google Scholar
• Salyers AA, Speer BS, Shoemaker NB. New perspectives in tetracycline resistance. Mol Microbiol 1990; 4:151 - 6; http://dx.doi.org/10.1111/j.1365-2958.1990.tb02025.x; PMID: 2181236
   PubMed Web of Science ®Google Scholar
• Dasti JI, Gross U, Pohl S, Lugert R, Weig M, Schmidt-Ott R. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2007; 56:833 - 7; http://dx.doi.org/10.1099/jmm.0.47103-0; PMID: 17510271
   PubMed Web of Science ®Google Scholar
• Taylor DE. Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant. J Bacteriol 1986; 165:1037 - 9; PMID: 3005233
   PubMed Web of Science ®Google Scholar
• Batchelor RA, Pearson BM, Friis LM, Guerry P, Wells JM. Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology 2004; 150:3507 - 17; http://dx.doi.org/10.1099/mic.0.27112-0; PMID: 15470128
   PubMed Web of Science ®Google Scholar
• Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother 1988; 32:1107 - 12; http://dx.doi.org/10.1128/AAC.32.8.1107; PMID: 3056250
   PubMed Web of Science ®Google Scholar
• Sahin O, Plummer PJ, Jordan DM, Sulaj K, Pereira S, Robbe-Austerman S, et al. Emergence of a tetracycline-resistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States. J Clin Microbiol 2008; 46:1663 - 71; http://dx.doi.org/10.1128/JCM.00031-08; PMID: 18322054
   PubMed Web of Science ®Google Scholar
• Bérdy J. CRC handbook of antibiotic compounds. Boca Raton, Fla.: CRC Press; 1980.
   Google Scholar
• Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol 2006; 70:140 - 50; http://dx.doi.org/10.1007/s00253-005-0279-0; PMID: 16391922
   PubMed Web of Science ®Google Scholar
• Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 1987; 51:439 - 57; PMID: 3325794
   PubMedGoogle Scholar
• Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 1983; 23:835 - 45; http://dx.doi.org/10.1128/AAC.23.6.835; PMID: 6351731
   PubMed Web of Science ®Google Scholar
• Bryan LE, Van Den Elzen HM. Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) 1975; 28:696 - 703; http://dx.doi.org/10.7164/antibiotics.28.696; PMID: 810469
   PubMed Web of Science ®Google Scholar
• Hermann T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci 2007; 64:1841 - 52; http://dx.doi.org/10.1007/s00018-007-7034-x; PMID: 17447006
   PubMed Web of Science ®Google Scholar
• Ouellette M, Gerbaud G, Lambert T, Courvalin P. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae. Antimicrob Agents Chemother 1987; 31:1021 - 6; http://dx.doi.org/10.1128/AAC.31.7.1021; PMID: 2821885
   PubMed Web of Science ®Google Scholar
• Tenover FC, Fennell CL, Lee L, LeBlanc DJ. Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant. Antimicrob Agents Chemother 1992; 36:712 - 6; http://dx.doi.org/10.1128/AAC.36.4.712; PMID: 1503433
   PubMed Web of Science ®Google Scholar
• Tenover FC, Filpula D, Phillips KL, Plorde JJ. Cloning and sequencing of a gene encoding an aminoglycoside 6′-N-acetyltransferase from an R factor of Citrobacter diversus. J Bacteriol 1988; 170:471 - 3; PMID: 2826403
   PubMed Web of Science ®Google Scholar
• Tenover FC, Gilbert T, O’Hara P. Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid 1989; 22:52 - 8; http://dx.doi.org/10.1016/0147-619X(89)90035-8; PMID: 2550983
   PubMed Web of Science ®Google Scholar
• Olkkola S, Juntunen P, Heiska H, Hyytiäinen H, Hänninen ML. Mutations in the rpsL gene are involved in streptomycin resistance in Campylobacter coli. Microb Drug Resist 2010; 16:105 - 10; http://dx.doi.org/10.1089/mdr.2009.0128; PMID: 20370506
   PubMed Web of Science ®Google Scholar
• Hannula M, Hänninen ML. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2008; 57:851 - 5; http://dx.doi.org/10.1099/jmm.0.47823-0; PMID: 18566143
   PubMed Web of Science ®Google Scholar
• Pumbwe L, Piddock LJV. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett 2002; 206:185 - 9; http://dx.doi.org/10.1111/j.1574-6968.2002.tb11007.x; PMID: 11814661
   PubMed Web of Science ®Google Scholar